Although tobacco smoking has been reported as a risk factor for liver cancer, few studies have specifically explored the association among Chinese females and the potential interaction between smoking and other risk factors. A population-based case-control study was conducted and 2,011 liver cancer cases and 7,933 healthy controls were enrolled in Jiangsu, China from 2003 to 2010. Epidemiological data were collected, and serum hepatitis B surface antigen (HBsAg) and anti-HCV antibody were measured. Unconditional logistic regression was used to examine association and potential interaction, while semiBayes (SB) method was employed to make estimates more conservative. The prevalence of serum HBsAg positivity was 43.2% among cases and 6.5% among controls. The adjusted odds ratios (OR) for ever smoking were 1.62 (95% confidence interval [CI]: 1.33-1.96) among male and 0.82 (95% CI: 0.53-1.26) among female. Age at first cigarette, duration of smoking and pack-years of smoking were all significantly associated with liver cancer among men. Compared to HBsAg-negative never smokers, the adjusted ORs were 1.25 (95% CI: 1.03-1.52) for HBsAg-negative ever smokers, 7.66 (95% CI: 6.05-9.71) for HBsAg-positive never smokers, and 15.68 (95% CI: 12.06-20.39) for HBsAg-positive ever smokers. These different odds ratios indicated super-additive (RERI: 7.77, 95% CI: 3.81-11.73) and super-multiplicative interactions (ROR: 1.64, 95% CI: 1.17-2.30) between hepatitis B virus (HBV) infection and tobacco smoking. Most associations and interactions detected remained statistically significant after SB adjustments. Tobacco smoking and HBV infection positively interact in the development of liver cancer.
accumulated and a recent metaanalysis reported a positive association between current tobacco smoking and liver cancer risk (risk ratio [RR]: 1.55, 95% confidence interval [CI]: 1.46-1.65), 2 suggesting a causal role of smoking in liver cancer development.
The metabolites of several tobacco smoke carcinogens including benzo[a]pyrene (BaP), nicotine-derived nitrosamine ketone (NNK), N 0 -nitrosonornicotine (NNN) bind to DNA or cause genotoxicity. 1 The metabolism of these carcinogens relies on cytochrome P450 system. 3 On the other hand, cirrhosis due to excess alcohol consumption is an independent risk factor of liver cancer. 4 Alcohol as an inducer of the microsomal cytochrome P450 transformation system, may have impact on the activation and inactivation of carcinogenic chemicals including those from tobacco smoke. 5 It is possible that alcohol use may have an impact on metabolism of tobacco carcinogens in liver. Furthermore, chronic hepatitis B and C are major contributors to liver cancer, and account for more than eighty percent of liver cancer incidence. 6 Long-term inflammation, viral replication and irregular regeneration of the liver caused by hepatitis C, and oncogenic events including transactivation of protooncogenes, inactivation of tumor suppressor genes, impairment of DNA repair mechanisms, enhanced expression of growth factors and deregulation of cell cycle, etc. caused by the hepatitis B virus (HBV) lead to cirrhosis and liver cancer development, 6 which will also affect the metabolic process of tobacco-related carcinogens. Thus, it is possible that chronic hepatitis, alcohol abuse and tobacco smoking may play a role in liver carcinogenesis both independently and jointly. For individual epidemiologic studies, since liver cancer is a rare disease, some of the cohort and case-control studies were limited by sample size for more detailed exploration of the relative risk in subgroups of population, as well as for more comprehensive control of confounding due to hepatitis virus infection or excess alcohol consumption. Also, these methodological limitations make it difficult to evaluate potential interactions between smoking and other risk factors. 7, 8 Most of the previously published studies used stratified analyses to examine the potential heterogeneity in associations between tobacco and liver cancer. One metaanalysis reported a super-additive interaction between HBV infection and cigarette smoking (synergy index [S] 5 1.44, 95% CI: 1.00-2.06), and a super-multiplicative interaction between HCV infection and cigarette smoking (ratio of Odds ratio [OR] 5 1.60, 95% CI: 1.16-2.20) based on nine and six studies, respectively. 9 However, these studies varied by study design and population, had different confounding variables controlled or reported crude ORs instead of adjusted ones, suggesting further investigation is needed.
No country in the world is more seriously affected by liver cancer than China, accounting for half of the world's incident liver cancer cases each year. 10 The prevalence of established risk factors such as HBV infection, alcohol drinking and tobacco smoking are high in Chinese population. The prevalence of hepatitis B surface antigen (HBsAg) positivity was estimated to be 7.2% in the general population aged 1-59 in 2006. 11 Meanwhile, it was reported that 52.9% men and 2.4%
women were current smokers in 2010, 12 and 55.6% men and 15.0% women were current drinkers in 2007. 13 Most published studies have not explored the association between smoking and liver cancer among Chinese women due to inadequate sample size since Chinese women have a much lower prevalence of tobacco smoking. We conducted a population-based case-control study in Jiangsu Province with 2,011 newly diagnosed liver cancer cases and 7,933 healthy controls. The aim of our study was to evaluate the association between tobacco smoking and liver cancer among males and females and the interactions between tobacco smoking and other major liver cancer risk factors, including HBV infection, HCV infection, alcohol drinking and family history of liver cancer.
Methods

Study design
A population-based case-control study was conducted to explore risk factors of four common cancers, including lung, stomach, esophagus and liver cancer in Jiangsu Province, China from 2003 to 2010. A detailed description of the study design and data collection has been described elsewhere.
14 Four counties, including Dafeng, Ganyu, Chuzhou and Tongshan, in northern Jiangsu were selected as study sites, in which population-based cancer registries were established in the 1990s.
Subjects
Newly diagnosed liver cancer cases were enrolled from January 1, 2003 identified from each county's demographic registry. Controls were required to be within the same gender and age group (65 years) as cases. One healthy control was randomly selected from a list of eligible residents for each case. Both cases and controls were 18 years or older, had been residents at the study site for >5 years and had no history of cancer diagnosis. In this analysis, matching was broken and all controls from the four parallel studies were combined together to increase the statistical power. The participation rates were 37% for liver cancer cases and 87% for controls.
Data collection
The study was approved by the Institutional Review Board (IRB) of Jiangsu Provincial Health Department and the IRB of University of California, Los Angeles. Written informed consent was obtained from each participant before the inperson interview. Epidemiological data were collected during face-to-face interviews by trained public health professionals, using a standard questionnaire. Data on sociodemographic characteristics, tobacco use, alcohol drinking, diet and lifestyle, history of raw water drinking, exposure to mildewcontaminated food intake and family history of liver cancer were collected. Tobacco smoking measurements were collected and defined in the following manner. Participants reporting a smoking history of 100 cigarettes or more were considered ever smokers; everyone else was considered never smokers. The ever smokers were then asked if they had ever quit smoking. If the participant answered yes, then the number of years since smoking cessation was collected. Those who quit smoking within one year were counted as current smokers. Ever smokers were asked about the types of tobacco they smoked, including cigarettes, water pipes and long-stemmed Chinese pipes. The age of first tobacco use, total years of smoking and number of cigarettes smoked every day were asked. If the participants smoked water pipes or longstemmed Chinese pipes, the monthly amount of tobacco leaves consumed was recorded and then transformed to a corresponding number of cigarettes.
Six to eight milliliters of blood was collected from participants after the interview and processed and stored at the Jiangsu CDC in 2708C freezers. Serum HBsAg and anti-HCV antibody were measured using enzyme-linked immunosorbent assay (ELISA) kits (Kehua Bio-engineering Co., Ltd., Shanghai, China) according to the manufacturer's protocol.
Statistical analyses
All statistical analyses were performed using SAS 9.3 statistical software (SAS Institute Inc., Cary, NC). Student's t test was used to compare the means of continuous variables between cases and controls. v 2 tests were used to compare the distribution of categorical variables. Unconditional logistic regression was used to estimate the crude ORs, adjusted ORs and their 95% CIs in comparing liver cancer risk across levels of covariates. The confounding variables adjusted in the models included: study site (Dafeng, Ganyu, Chuzhou, Tongshan, entered the models as dummy variables), gender (male, female), age (continuous), education level (illiteracy, primary school, middle school, high school and college, entered the models as dummy variables), marital status (married, single, divorced or widowed), per capita family income 10 years ago (Yuan/year, RMB, continuous), body mass index (BMI, continuous), weekly alcohol intake in the 1990s (mL/ week, continuous), history of raw water drinking (yes or no), history of mildew-contaminated food intake (yes or no), HBV infection (HBsAg status, positive or negative), HCV infection (anti-HCV, positive or negative) and having family history of liver cancer (yes or no). Relative excess risk due to interaction (RERI), attributable proportion due to interaction (AP), and synergy index (S) with 95% CIs were calculated to examine interaction on the additive scale while ratio of the odds ratios (ROR) was calculated to examine interaction on the multiplicative scale. 15 Let OR ij be an approximation for the RR in exposure category i,j, OR 11 , OR 10 15 To reduce the possibility of false positive findings after multiple comparisons performed in the analyses, a semi-Bayes (SB) approach was employed. The prior was set to have a coefficient of mean zero, corresponding to an OR of one (null, no association), with a variance of 0.5. This use of shrinkage estimation pulls the estimates toward the null, makes the posterior estimates more conservative and accurate than the observed ones. 16 A two-sided p-values <0.05 was considered statistically significant. Table 1 shows the sociodemographic characteristics of the 2,011 liver cancer cases and 7,933 controls included in our study. The mean age was 58.7 (SD 5 12.2) years old for cases and 63.9 (SD 5 11.4) years old for controls (p < 0.001). A higher proportion of cases was male, had at least an elementary education, and was married compared to controls (p < 0.001). Cases and controls also differed in per capita family income 10 years ago and in BMI (p < 0.05). For major risk factors of liver cancer, more cases were HBsAg positive (43.2% vs. 6.5%, p < 0.001), were ever drinkers (56.0% vs. 46.4%, p < 0.001) and had a family history of liver cancer (13.7% vs. 3.1%, p < 0.001). The prevalence of anti-HCV positivity was 0.9% among liver cancer cases and 0.8% among healthy controls (p 5 0.751).
Results
Among 7,933 controls, 57.9% of men and 17.4% of women were ever smokers, and 44.0% of men and 12.2% of women were current smokers. By comparison, 63.4% of men and 14.3% of women were ever smokers among the 2,011 cases, while 46.2% of men and 9.3% of women were current smokers. The association between tobacco smoking and the risk of liver cancer was analyzed altogether first and then by gender (Table 2) The potential interactions between tobacco smoking and other major risk factors of liver cancer were examined on both additive and multiplicative scales (Table 3 ). Compared to HBsAg-negative never smokers, the adjusted ORs were 1.25 (95% CI: 1.03-1.52) for HBsAg-negative ever smokers, 7.66 (95% CI: 6.05-9.71) for HBsAg-positive never smokers, and 15.68 (95% CI: 12.06-20.39) for HBsAg-positive ever smokers. The interaction was both super-additive, reporting RERI of 7.77 (95% CI: 3.81-11.73), AP of 0.50 (95% CI: 0.35-0.64) and S of 2.12 (95% CI: 1.53-2.94), and supermultiplicative, reporting ROR of 1.64 (95% CI: 1.17-2.30). The interaction between ever smoking and other major risk factors including anti-HCV positive was examined and no significant interaction was detected (Table 3) .
Using the prevalence of ever smoking in the control group of 46.5% as the population prevalence, and using the adjusted OR of 1.43 as the approximation for the RR, the population attributable risk of ever smoking was estimated to be 16.7%.
Discussion
In this large-scale population-based case-control study, tobacco smoking was confirmed to be positively associated with liver cancer with an adjusted OR of 1.43 (95% CI: 1.20-1.70) comparing ever smokers to never smokers after controlling for confounding and applying a conservative SB adjustment. Stratified analyses by gender showed that the associations mainly existed in males. A positive interaction between smoking and HBV infection was detected.
We reported an adjusted OR of 1.43 (95% CI: 1.19-1.73) for the association between current smoking and risk of liver cancer. This estimate was similar to the result from a metaanalysis for 38 cohort and 58 case-controls studies (mRR of 1.51, 95% CI: 1.37-1.67). 17 Former smoking showed higher ORs than current smoking with liver cancer in the analyses, probably because those who stopped smoking quitted due to weaker health conditions or onset of respiratory symptoms. Additionally, our estimate was based on a relatively comprehensive confounding control including adjustment for HBV infection, HCV infection, alcohol consumption, possibility of mildew-contaminated food intake, raw water drinking and family history of liver cancer. Although we were not able to measure aflatoxin exposure directly, we asked about participants' historical intake of mildew-contaminated food and included the variable in regression models. Furthermore, the SB adjustment reported a similar estimate (SB-adjusted OR: 1.42, 95% PI: 1.20-1.69), confirming tobacco smoking as a moderate risk factor for liver cancer after accounting for major confounding. Heterogeneity was found in the associations examined by gender. Positive associations between smoking behaviors and 
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Liu et al. Cancer Epidemiology liver cancer were observed among men. Age at first tobacco use, daily amount of cigarette smoking, total years of smoking and pack-years of smoking were positively associated with liver cancer among male participants. Several cohort studies have been conducted among men [18] [19] [20] [21] [22] [23] [24] or have reported relative risks among men. 25, 26 The Taiwan mortality study reported an age-adjusted RR of 1.46 (95% CI: 1.18-1.82) for current male smokers with a dose-response pattern. 26 Two other studies performed in Taiwan reported slightly increased but nonsignificant risks for smokers. 20, 21 One study followed up 18,244 men in Shanghai and reported an RR of 1.8 (95% CI: 0.6-5.6) for ever smoking, adjusting for education level, HBsAg status, presence of urinary aflatoxins/DNA-adducts and heavy (30 g/day) alcohol consumption. 19, 23 The Haimen study followed up 58,545 men and reported an age-adjusted RR of 0.9 (95% CI: 0.8-1.1) for current smokers. 25 The nonsignificant associations were probably due to the limited number of liver cancer cases that developed in the populations. Results for women in our study did not show significant association between cigarette smoking and liver cancer risk. Several cohort studies have reported increased risk for women who smoked compared to nonsmokers, [25] [26] [27] while two cohorts from Korea and Japan did not observe a significant association. 28, 29 None of these five studies controlled for viral hepatitis infection, and only one controlled for alcohol consumption. Based on these results and our observations, we have not found the conclusive evidence for association between tobacco smoking and liver cancer risk in female.
Positive interaction on both additive and multiplicative scale was detected between tobacco smoking and HBV infection. One metaanalysis examining the interaction between cigarette smoking and chronic HBV infection calculated S of 1.44 (95% CI: 1.00-2.06) and V (same as the ROR in our study) of 0.87 (95% CI: 0.58-1.29). 9 Our results provide further evidence with larger sample size and comprehensive confounding control. In previous studies, the associations between tobacco smoking and liver cancer stratified by HBV infection have been controversial. Some studies observed associations between heavy tobacco smoking and liver cancer risk among HBV positive participants, 30 while others observed significant associations only among HBV negative participants. [31] [32] [33] [34] Our results suggest a joint effect between HBV infection and cigarette smoking in liver cancer development.
There were several limitations to our study. First of all, since liver cancer progresses very quickly, some cases deteriorated and were not able to participate in the study or died before being reached by our study staff. Selection bias may exist in our analyses because data was collected from those who tended to be in better health or were otherwise stronger than those who did not participate. Secondly, as a case-control study, all the exposure data was collected after disease diagnosis. Behaviors such as alcohol drinking and cigarette smoking among the cases might have changed after diagnosis and could inaccurately represent the lifetime exposure status, leading to an underestimation of the association. However, the interview was performed soon after the diagnosis, which may minimize the possibility of behavior change. Also, tobacco smoking was not a well-known risk factor for liver cancer in this population, and the likelihood of exaggeration in reporting this behavior would be low. Additionally, we used the history of possibility of mildew-contaminated food intake as a proxy of aflatoxin exposure in the regression models, which might suffer from residual confounding. The Shanghai men study reported RR of 2.4 (95% CI: 1.0-5.9) for aflatoxin metabolites of liver cancer, 19 which might indicate that our results may have underestimated the impact of aflatoxin exposure. Last but not least, our results showed that the association between tobacco smoking and liver cancer existed after adjusting for alcohol consumption, which was consistent with the observation from many other studies including those in Chinese populations. 23, 35, 36 However, since heavy smokers are more likely to be heavy drinkers as well, the possibility of over adjustment may exist when including alcohol consumption in the models.
In conclusion, we confirmed a positive association between tobacco smoking and risk of liver cancer in a Chinese population-based case-control study with a large sample size. This result is significant among males in this population. Positive interaction between tobacco smoking and HBV has been observed. It is of importance to conduct tobacco interventions especially those targeting individuals with HBV infection.
